Continuous subcutaneous carbidopa improves levodopa pharmacokinetics in Parkinson's disease patients

被引：0
|
作者：
Caraco, Y.
Giladi, N.
Oren, S.
LeWitt, P. A.
机构：
来源：
MOVEMENT DISORDERS | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
349
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [21] Design of a Pharmacokinetics Study with Multiple Doses of Accordion Pill™ Carbidopa/Levodopa in Patients with Parkinson's disease
    Olanow, C.
    Kieburtz, K.
    Dubow, J.
    Stocchi, F.
    Meckler, J.
    Navon, N.
    Gendreau, R.
    MOVEMENT DISORDERS, 2018, 33 : S118 - S118
  • [22] Continuous Administration of Subcutaneous Levodopa/Carbidopa (ND0612) Demonstrated Comparable Levodopa Pharmacokinetics to Levodopa/Carbidopa Intestinal Gel (LCIG)
    Adar, Liat
    Minei, Tamar Rachmilewitz
    Cohen, Yael
    Oren, Sheila
    NEUROLOGY, 2017, 88
  • [23] Levodopa/carbidopa/entacapone in Parkinson's disease
    Seeberger, Lauren C.
    Hauser, Robert A.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (07) : 929 - 940
  • [24] Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease
    Guthikonda, Lalitha N.
    Lyons, Kelly E.
    Pahwa, Rajesh
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2014, 3 (04) : 331 - 333
  • [25] The pharmacokinetics of patients with Parkinson's disease receiving levodopa-carbidopa intestinal gel infusion therapy
    Mukai, Y.
    Miyazaki, M.
    Mukai, T.
    Tasaki, A.
    Yuji, T.
    Murata, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 586 - 586
  • [26] Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease
    Delea, Thomas E.
    Thomas, Simu K.
    Hagiwara, May
    Mancione, L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1543 - 1552
  • [27] Transcutaneous Port for Continuous Duodenal Levodopa/Carbidopa Administration in Parkinson's Disease
    Meppelink, Anne Marthe
    Nyman, Rickard
    van Laar, Teus
    Drent, Martje
    Prins, Ted
    Leenders, Klaus Leonhard
    MOVEMENT DISORDERS, 2011, 26 (02) : 331 - 334
  • [28] Continuous subcutaneous levodopa/ carbidopa infusion for Parkinson's disease: 3-year data from the BeyoND study
    Poewe, W.
    Stocchi, F.
    Adar, L.
    Sopromadze, S.
    Yardeni, T.
    Giladi, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 313 - 313
  • [29] Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment
    Senek, Marina
    Aquilonius, Sten-Magnus
    Askmark, Hakan
    Bergquist, Filip
    Constantinescu, Radu
    Ericsson, Anders
    Lycke, Sara
    Medvedev, Alexander
    Memedi, Mevludin
    Ohlsson, Fredrik
    Spira, Jack
    Westin, Jerker
    Nyholm, Dag
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (05) : 563 - 571
  • [30] Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
    Marina Senek
    Sten-Magnus Aquilonius
    Håkan Askmark
    Filip Bergquist
    Radu Constantinescu
    Anders Ericsson
    Sara Lycke
    Alexander Medvedev
    Mevludin Memedi
    Fredrik Ohlsson
    Jack Spira
    Jerker Westin
    Dag Nyholm
    European Journal of Clinical Pharmacology, 2017, 73 : 563 - 571
12345